Medicenna Therapeutics Corp.
MDNAF · OTCMCIK 1807983fmd_0F14EPZ4ZXR28MZST4RYXJE6QYManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Apr 01, 2019 to Mar 31, 2023, 4 periods
| Line item | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|
| Research and development | 6 | 11 | 15 | 9 |
| Income before taxes | (8) | (17) | (23) | (10) |
| Income tax expense | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (8) | (17) | (23) | (10) |
| Net income | (8) | (17) | (23) | (10) |